Clinical implications of PROGRESS: questions and answers.
Chalmers
John
J
Institute for International Health, University of Sydney, Newtown, NSW, Australia. chalmers@iih.usyd.edu.au
Adams
Harold P
HP
Donnan
Geoffrey A
GA
Fox
Kim
K
MacMahon
Stephen
S
Mancia
Giuseppe
G
Tzourio
Christophe
C
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D020913:Perindopril / Q000627:therapeutic use*; D055502:Secondary Prevention; D020521:Stroke / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D020913:Perindopril